Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with meth...

by Hirani SP, Kassoumeri L, Mulligan K, Ruperto N, Woo P, Wedderburn LR, Newman SP
Published 2008-09-01

A meta-analysis to estimate the “real” placebo effect in juvenile idiopathic arthritis (JIA) trials

by Martini A, Palmisani E, Ravelli A, Galasso R, Ruperto N, Demirkaya E, Pistorio A
Published 2011-09-01

Investigating the use of a limited core outcome variable set for the classification of response following methotrexate treatment in juvenile idiopathic arthritis (JIA)

by Hirani SP, Kassoumeri L, Etheridge A, Mulligan K, Ruperto N, Woo P, Wedderburn L, Newman SP
Published 2008-09-01

Comparison of the accuracy of different definitions of clinical remission (CR) and minimal disease activity (MDA) in juvenile idiopathic arthritis (JIA)

by Davì S, Consolaro A, Ferrari C, Federici S, Vitale R, Filocamo G, Loy A, Ruperto N, Martini A, Ravelli A
Published 2008-09-01

Development and initial validation of the parent acceptable symptom state in juvenile idiopathic arthritis (JIA)

by Filocamo G, Schiappapietra B, Manzoni S Magni, Lanni S, Solari N, Viola S, Pistorio A, Ruperto N, Tani D, Martini A, Ravelli A
Published 2008-09-01

A new approach to defining inactive disease, minimal disease activity and parent- and child-acceptable symptom state in juvenile idiopathic arthritis

by Bertamino M, Filocamo G, Consolaro A, Palmisani E, Bracciolini G, Suffia C, Muratore V, Ruperto N, Martini A, Ravelli A
Published 2011-09-01

Evaluation of the power of six clustering features in identifying a homogeneous disease subset in juvenile idiopathic arthritis (JIA)

by Magnani A, Oliveira S, Castell E, Arguedas O, Ullmann N, Pederzoli S, Manzoni S Magni, Pistorio A, Ruperto N, Martini A, Ravelli A
Published 2008-09-01

Impact of involvement of individual joint groups on subdimensions of functional ability scales in juvenile idiopathic arthritis

by Meiorin S, Filocamo G, Palmisani E, Sala I, Manzoni S Magni, Lanni S, Viola S, Buoncompagni A, Pistorio A, Ruperto N, Martini A, Ravelli A
Published 2008-09-01

2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic J...

by Ruperto N, Quartier P, Wulffraat N, Woo P, Loy A, Mouy R, Bader-Meunier B, Prakken B, Noseda E, Rordorf C
Published 2008-09-01

Development and initial validation of a new short and simple Health-Related Quality Of Life (HRQL) Questionnaire for Pediatric Rheumatic Diseases (PRD)

by Palmisani E, Filocamo G, Saad-Magalhaes C, Consolaro A, Magni-Manzoni S, Viola S, Pistorio A, Ruperto N, Tani D, Serpico S, Martini A, Ravelli A
Published 2008-09-01

Preliminary validation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 403 clinic patients

by Solari N, Filocamo G, Schiappapietra B, Consolaro A, Magni-Manzoni S, Viola S, Ruperto N, Saad-Magalhaes C, Tani D, Serpico S, Martini A, Ravelli A
Published 2008-09-01

Final validation of a new composite disease activity score for juvenile idiopathic arthritis: the Juvenile Arthritis Disease Activity Score (JADAS)

by Consolaro A, Ruperto N, Bazso A, Magni-Manzoni S, Pelagatti MA, Pistorio A, Magnani A, Malattia C, D'Agostino I, Filocamo G, Martini A, Ravelli A
Published 2008-09-01

Abatacept treatment improves health-related quality of life, pain, and sleep quality in juvenile idiopathic arthritis patients

by Ruperto N, Lovell DJ, Li T, Quartier P, Chavez J, Huemer C, Kivitz A, Blanco F, Foeldvari I, Hofer M, Sigal L, Block A, Covucci A, Martini A, Giannini EH
Published 2008-09-01

Reduction in missed school days and improvement in parent activity participation in children with juvenile idiopathic arthritis treated with abatacept

by Ruperto N, Lovell DJ, Li T, Paz E, Horneff G, Huppertz HI, Deslandre CJ, Minden K, Punaro M, Nunez AF, Sigal L, Block A, Covucci A, Martini A, Giannini EH
Published 2008-09-01

Therapeutic approaches for the treatment of new onset and flared juvenile systemic lupus erythematosus with active renal disease: an international multicenter PRINTO study

by Palmisani E, Sztajnbok F, Porras O, Ozen S, Cortis E, Pasic S, Espada G, Mihaylova D, Cuttica R, Alessio M, Oliveira S, Ravelli A, Pistorio A, Miettunen P, Martini A, Ruperto N
Published 2011-09-01

Long-term efficacy and safety of adalimumab in 4-12 year old patients with juvenile idiopathic arthritis

by Wouters C, McIlraith MJ, Ilowite N, Chalom E, Jones OY, Koné-Paut I, Higgins G, Gamir M, Reiff A, Lovell DJ, Ruperto N, Liu S, Kupper H, Giannini EH, Martini A
Published 2011-09-01

Prevalence of monogenic autoinflammatory diseases among Pediatric Rheumatology centers: the Eurofever PReS/PRINTO survey

by Gattorno M, Frenkel J, Ozen S, De Benedetti F, Konè-Paut I, Neven N, Girschick H, Özdogan H, Wouters C, Woo P, Hofer M, Dolezalova P, Toplak N, Richard V, Martini A, Ruperto N
Published 2008-09-01

The PRINTO provisional definition of remission in juvenile dermatomyositis

by Kasapcopur O, Ganser G, Ferriani V, Penades I, Dolezalova P, Quartier P, Hofer M, Garay S, Wulffraat N, Pilkington C, Malattia C, Ravelli A, Miettunen P, Pistorio A, Lazarevic D, Melo-Gomes JA, Wierzbowska M, Martini A, Ruperto N
Published 2011-09-01

Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a...

by McCann L, Ozdogan H, Rutkowska-Sak L, Ferrandiz MA, Wulffraat NM, Brik R, Kallinich T, Erguven M, Berkun Y, Constantin T, Quartier P, Horneff G, Brunner H, Ruperto N, Lheritier K, Preiss R, Tseng L, Martini A, Lovell DJ
Published 2011-09-01

2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatme...

by Ruperto N, Lovell DJ, Cuttica R, Woo P, Espada G, Wouters C, Silverman ED, Balogh Z, Henrickson M, Davidson J, Foeldvari I, Imundo L, Simonini G, Oppermann J, Shen YK, Visvanathan S, Fasanmade A, Mendelsohn A, Martini A, Giannini EH
Published 2008-09-01